This Company Hopes To Make You Smarter — And Richer — Than Your Parents

Maybe you’ve seen the 2011 movie “Limitless,” where a seemingly hopeless and failing writer named Eddie (played by Bradley Cooper) is given a pill that gives him a four-digit IQ.

It’s a fun movie but based on two absurdities. The first is that the pill unlocks the 90% of the brain that can’t be accessed, allowing humans to use their brains in their entirety for the first time ever. But it’s a myth that we only use 10% of our minds.

The second absurdity is that Eddie, with an IQ supposedly five times greater than Albert Einstein’s, still doesn’t understand the power of compound interest. With his superintelligence, he’s able to use algorithms to game Wall Street and double his money every few days. But he turns to criminal enterprises after judging his money isn’t growing fast enough — even though someone doubling $100 every few days will become the richest human in history within months.

At the same time, it’s undeniable that a few factors — sleep, vibrant social life and proper nutrition — can enhance brain function. And it’s an open debate in the medical community whether some supplements or brain foods that are often loaded with essential vitamins and minerals can actually boost cognitive functions — in effect, making people smarter.

A “Limitless” pill like the one that turned Cooper into a demigod is pie in the sky for researchers, of course. But products to improve brain function don’t have to dramatically rewire our minds. By combating the three biggest culprits for impaired brain function – stress, inadequate sleep and nutrient deficiency – a brain boost product could make its users livelier, wittier, more creative and energized and dramatically improve memory while flattening their learning curves.

And that’s exactly TruBrain has set out to achieve.

Since its founding in 2012, TruBrain has logged $18 million in sales for its brain-boosting products. The company offers a line of brain foods to boost memory, focus and verbal fluency in the form of capsules, nutrition bars and 1-ounce drinks.

From an investing standpoint, TruBrain has been profitable since 2019. That’s a significant milestone because the brain health supplement industry has years of exponential growth ahead of it, according to P&S Intelligence, which forecasts a market of over $15 billion by 2030.

But the real differentiator for truBrain might be its wearable device that monitors stress signals. Wearable, which received approval from the Food and Drug Administration on Nov. 3, is an unobtrusive monitoring device. It’s the company’s earliest foray into the wearable technology industry that’s projected to hit over $100 billion globally by 2030.

Claiming a portion of this booming market could be momentous for a small-cap company that’s only recently turned profitable, though as with any investment, risks are involved.

TruBrain shares are priced at $0.43 through its Regulation A offering on StartEngine.